Exploring phosphatidylinositol 5-phosphate 4-kinase function

Advances in Biological Regulation

Volumn 57, Issue , 2015, Pages 193-202

  Bulley, Simon J ^a   Clarke, Jonathan H ^a   Droubi, Alaa ^a   Giudici, Maria Luisa ^a   Irvine, Robin F ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Inositide; Kinase; Phosphatidylinositol; Phosphatidylinositol 5 phosphate; Phosphatidylinositol 5 Phosphate4 kinase

Indexed keywords

1-PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE; PHOSPHATIDYLINOSITOL 5-PHOSPHATE; PHOSPHOTRANSFERASE; POLYPHOSPHOINOSITIDE;

ANIMAL; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SIGNAL TRANSDUCTION;

EID: 84920775476     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2014.09.007     Document Type: Review

References (58)

1. Alvarez-Venegas R., Sadder M., Hlavacka A., Baluska F., Xia Y., Lu G., et al. The Arabidopsis homolog of trithorax, ATX1, binds phosphatidylinositol 5-phosphate, and the two regulate a common set of target genes. Proc Natl Acad Sci USA 2006, 103:6049-6054.
2. Boronenkov I.V., Loijens J.C., Umeda M., Anderson R.A. Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing pre-mRNA processing factors. Mol Biol Cell 1998, 9:3547-3560.
3. Bridges D., Ma J.T., Park S., Inoki K., Weisman L.S., Saltiel A.R. Phosphatidylinositol 3,5-bisphosphate plays a role in the activation and subcellular localization of mechanistic target of rapamycin 1. Mol Biol Cell 2012, 23:2955-2962.
4. Bua D.J., Martin G.M., Binda O., Gozani O. Nuclear phosphatidylinositol-5-phosphate regulates ING2 stability at discrete chromatin targets in response to DNA damage. Sci Reports 2013, 3:2137.
5. Bultsma Y., Keune W.J., Divecha N. PIP4Kβ interacts with and modulates nuclear localisation of the high activity PtdIns5P-4-kinase isoform, PIP4Kα. Biochem J 2010, 430:223-235.
6. Bunce M.W., Boronenkov I.V., Anderson R.A. Coordinated activation of the nuclear ubiquitin ligase Cul3-SPOP by the generation of phosphatidylinositol 5-Phosphate. JBiol Chem 2008, 283:8678-8686.
7. Cabezas A., Pattni K., Stenmark H. Cloning and subcellular localization of a human phosphatidylinositol 3-phosphate 5-kinase, PIKfyve/Fab1. Gene 2006, 371:34-41.
8. Campbell R.B., Liu F., Ross A.H. Allosteric activation of PTEN phosphatase by phosphatidylinositol 4,5-bisphosphate. JBiol Chem 2003, 278:33617-33620.
9. Carricaburu V., Lamia K.A., Lo E., Favereaux L., Payrastre B., Cantley L.C., et al. The phosphatidylinositol (PI)-5-phosphate 4-kinase type II enzyme controls insulin signaling by regulating PI-3,4,5-trisphosphate degradation. Proc Natl Acad Sci USA 2003, 100:9867-9872.
10. Ciruela A., Hinchliffe K.A., Divecha N., Irvine R.F. Nuclear targeting of the β isoform of Type II phosphatidylinositol phosphate kinase (phosphatidylinositol 5-phosphate 4-kinase) by its α-helix 7. Biochem J 2000, 364:587-591.
11. Clarke J.H., Emson P.C., Irvine R.F. Localization of phosphatidylinositol phosphate kinase IIgamma in kidney to a membrane trafficking compartment within specialized cells of the nephron. Am J Physiol Ren Physiol 2008, 295:F1422-F1430.
12. Clarke J.H., Irvine R.F. The activity, evolution and association of phosphatidylinositol 5-phosphate 4-kinases. Adv Biol Regul 2012, 52:40-45.
13. Clarke J.H., Irvine R.F. Evolutionarily conserved structural changes in phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) isoforms are responsible for differences in enzyme activity and localization. Biochem J 2013, 454:49-57.
14. Clarke J.H., Letcher A.J., D'Santos C.S., Halstead J.R., Irvine R.F., Divecha N. Inositol lipids are regulated during cell cycle progression in the nuclei of murine erythroleukaemia cells. Biochem J 2001, 357:905-910.
15. Davis M.I., Sasaki A.T., Shen M., Emerling B.M., Thorne N., Michael S., et al. Ahomogeneous, high-throughput assay for phosphatidylinositol 5-phosphate 4-kinase with a novel, rapid substrate preparation. PLoS One 2013, 8:e54127.
16. Emerling B.M., Hurov J.B., Poulogiannis G., Tsukazawa K.S., Choo-Wing R., Wulf G.M., et al. Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors. Cell 2013, 155:844-857.
17. Gelato K.A., Tauber M., Ong M.S., Winter S., Hiragami-Hamada K., Sindlinger J., et al. Accessibility of different histone H3-binding domains of UHRF1 is allosterically regulated by phosphatidylinositol 5-Phosphate. Mol Cell 2014, 54:905-919.
18. Gozani O., Karuman P., Jones D.R., Ivanov D., Cha J., Lugovskoy A.A., et al. The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell 2003, 114:99-111.
19. Grainger D.L., Tavelis C., Ryan A.J., Hinchliffe K.A. Involvement of phosphatidylinositol 5-phosphate in insulin-stimulated glucose uptake in the L6 myotube model of skeletal muscle. Pflugers Arch 2011, 462:723-732.
20. Haugsten E.M., Oppelt A., Wesche J. Phosphatidylinositol 5-phosphate is a second messenger important for cell migration. Commun Integr Biol 2013, 6:e25446.
21. Hinchliffe K.A., Giudici M.L., Letcher A.J., Irvine R.F. Type IIalpha phosphatidylinositol phosphate kinase associates with the plasma membrane via interaction with type I isoforms. Biochem J 2002, 363:563-570.
22. Ikonomov O.C., Sbrissa D., Mlak K., Shisheva A. Requirement for PIKfyve enzymatic activity in acute and long-term insulin cellular effects. Endocrinology 2002, 143:4742-4754.
23. Jefferies H.B., Cooke F.T., Jat P., Boucheron C., Koizumi T., Hayakawa M., et al. Aselective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral budding. EMBO Reports 2008, 9:164-170.
24. Jones D.R., Bultsma Y., Keune W.J., Halstead J.R., Elouarrat D., Mohammed S., et al. Nuclear PtdIns5P as a transducer of stress signaling: an invivo role for PIP4Kbeta. Mol Cell 2006, 23:685-695.
25. Jones D.R., Foulger R., Keune W.J., Bultsma Y., Divecha N. PtdIns5P is an oxidative stress-induced second messenger that regulates PKB activation. FASEB J 2013, 27:1644-1656.
26. Jude J.G., Spencer G.J., Huang X., Somerville T.D., Jones D.R., Divecha N., et al. Atargeted knockdown screen of genes coding for phosphoinositide modulators identifies PIP4K2A as required for acute myeloid leukemia cell proliferation and survival. Oncogene 2014, 10.1038/onc.2014.77.
27. Kawasaki T., Takemura N., Standley D.M., Akira S., Kawai T. The second messenger phosphatidylinositol-5-phosphate facilitates antiviral innate immune signaling. Cell Host Microbe 2013, 14:148-158.
28. Keune W.J., Jones D.R., Bultsma Y., Sommer L., Zhou X.Z., Lu K.P., et al. Regulation of phosphatidylinositol-5-phosphate signaling by Pin1 determines sensitivity to oxidative stress. Sci Signal 2012, 5:ra86.
29. Keune W.J., Jones D.R., Divecha N. PtdIns5P and Pin1 in oxidative stress signaling. Adv Biol Regul 2013, 53:179-189.
30. Keune W.J., Sims A.H., Jones D.R., Bultsma Y., Lynch J.T., Jirstrom K., et al. Low PIP4K2B expression in human breast tumors correlates with reduced patient survival: a role for PIP4K2B in the regulation of E-cadherin expression. Cancer Res 2013, 73:6913-6925.
31. Lamia K.A., Peroni O.D., Kim Y.B., Rameh L.E., Kahn B.B., Cantley L.C. Increased insulin sensitivity and reduced adiposity in phosphatidylinositol 5-phosphate 4-kinase beta-/- mice. Mol Cell Biol 2004, 24:5080-5087.
32. McEwen R.K., Dove S.K., Cooke F.T., Painter G.F., Holmes A.B., Shisheva A., et al. Complementation analysis in PtdInsP kinase-deficient yeast mutants demonstrates that Schizosaccharomyces pombe and murine Fab1p homologues are phosphatidylinositol 3-phosphate 5-kinases. JBiol Chem 1999, 274:33905-33912.
33. Nakatsu F., Baskin J.M., Chung J., Tanner L.B., Shui G., Lee S.Y., et al. PtdIns4P synthesis by PI4KIIIalpha at the plasma membrane and its impact on plasma membrane identity. JCell Biol 2012, 199:1003-1016.
34. Ndamukong I., Jones D.R., Lapko H., Divecha N., Avramova Z. Phosphatidylinositol 5-phosphate links dehydration stress to the activity of ARABIDOPSIS TRITHORAX-LIKE factor ATX1. PLoS One 2010, 5:e13396.
35. Niebuhr K., Giuriato S., Pedron T., Philpott D.J., Gaits F., Sable J., et al. Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology. EMBO J 2002, 21:5069-5078.
36. Nishimura K., Fukagawa T., Takisawa H., Kakimoto T., Kanemaki M. An auxin-based degron system for the rapid depletion of proteins in nonplant cells. Nat Methods 2009, 6:917-922.
37. Oppelt A., Haugsten E.M., Zech T., Danielsen H.E., Sveen A., Lobert V.H., et al. PIKfyve, MTMR3 and their product PtdIns5P regulate cancer cell migration and invasion through activation of Rac1. Biochem J 2014, 461:383-390.
38. Oppelt A., Lobert V.H., Haglund K., Mackey A.M., Rameh L.E., Liestol K., et al. Production of phosphatidylinositol 5-phosphate via PIKfyve and MTMR3 regulates cell migration. EMBO Reports 2013, 14:57-64.
39. Payrastre B., Gaits-Iacovoni F., Sansonetti P., Tronchere H. Phosphoinositides and cellular pathogens. Sub-Cellular Biochem 2012, 59:363-388.
40. Pendaries C., Tronchere H., Arbibe L., Mounier J., Gozani O., Cantley L., et al. PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection. EMBO J 2006, 25:1024-1034.
41. Ramel D., Lagarrigue F., Dupuis-Coronas S., Chicanne G., Leslie N., Gaits-Iacovoni F., et al. PtdIns5P protects Akt from dephosphorylation through PP2A inhibition. Biochem Biophys Res Commun 2009, 387:127-131.
42. Ramel D., Lagarrigue F., Pons V., Mounier J., Dupuis-Coronas S., Chicanne G., et al. Shigella flexneri infection generates the lipid PI5P to alter endocytosis and prevent termination of EGFR signaling. Sci Signal 2011, 4:ra61.
43. Redfern R.E., Redfern D., Furgason M.L., Munson M., Ross A.H., Gericke A. PTEN phosphatase selectively binds phosphoinositides and undergoes structural changes. Biochemistry 2008, 47:2162-2171.
44. Richardson J.P., Wang M., Clarke J.H., Patel K.J., Irvine R.F. Genomic tagging of endogenous type IIbeta phosphatidylinositol 5-phosphate 4-kinase in DT40 cells reveals a nuclear localisation. Cell Signal 2007, 19:1309-1314.
45. Roberts H.F., Clarke J.H., Letcher A.J., Irvine R.F. Effect of lipid kinase expression and cellular stimuli on phosphatidylinositol 5-phosphate levels in mammalin cell lines. FEBS Lett 2005, 579:2868-2872.
46. Sarkes D., Rameh L.E. Anovel HPLC-based approach makes possible the spatial characterization of cellular PtdIns5P and other phosphoinositides. Biochem J 2010, 428:375-384.
47. Sbrissa D., Ikonomov O.C., Filios C., Delvecchio K., Shisheva A. Functional dissociation between PIKfyve-synthesized PtdIns5P and PtdIns(3,5)P2 by means of the PIKfyve inhibitor YM201636. Am J Physiol Cell Physiol 2012, 303:C436-C446.
48. Sbrissa D., Ikonomov O.C., Shisheva A. PIKfyve, a mammalian ortholog of yeast Fab1p lipid kinase, synthesizes 5-phosphoinositides. Effect of insulin. JBiol Chem 1999, 274:21589-21597.
49. Sbrissa D., Ikonomov O.C., Strakova J., Shisheva A. Role for a novel signaling intermediate, phosphatidylinositol 5-phosphate, in insulin-regulated F-actin stress fiber breakdown and GLUT4 translocation. Endocrinology 2004, 145:4853-4865.
50. Schaletzky J., Dove S.K., Short B., Lorenzo O., Clague M.J., Barr F.A. Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases. Curr Biol 2003, 13:504-509.
51. Tolias K.F., Rameh L.E., Ishihara H., Shibasaki Y., Chen J., Prestwich G.D., et al. Type I phosphatidylinositol-4-phosphate 5-kinases synthesize the novel lipids phosphatidylinositol 3,5-bisphosphate and phosphatidylinositol 5-phosphate. JBiol Chem 1998, 273:18040-18046.
52. Ungewickell A., Hugge C., Kisseleva M., Chang S.C., Zou J., Feng Y., et al. The identification and characterization of two phosphatidylinositol-4,5-bisphosphate 4-phosphatases. Proc Natl Acad Sci USA 2005, 102:18854-18859.
53. Vaccari I., Dina G., Tronchere H., Kaufman E., Chicanne G., Cerri F., et al. Genetic interaction between MTMR2 and FIG4 phospholipid phosphatases involved in Charcot-Marie-Tooth neuropathies. PLoS Genet 2011, 7:e1002319.
54. Wang M., Bond N.J., Letcher A.J., Richardson J.P., Lilley K.S., Irvine R.F., et al. Genomic tagging reveals a random association of endogenous PtdIns5P 4-kinases IIα and IIβ and a partial nuclear localisation of the IIα isoform. Biochem J 2010, 430:215-221.
55. Wilcox A., Hinchliffe K.A. Regulation of extranuclear PtdIns5P production by phosphatidylinositol phosphate 4-kinase 2alpha. FEBS Lett 2008, 582:1391-1394.
56. Wu X., Chi R.J., Baskin J.M., Lucast L., Burd C.G., De Camilli P., et al. Structural insights into assembly and regulation of the plasma membrane phosphatidylinositol 4-kinase complex. Dev Cell 2014, 28:19-29.
57. Zolov S.N., Bridges D., Zhang Y., Lee W.W., Riehle E., Verma R., et al. Invivo, Pikfyve generates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5P. Proc Natl Acad Sci USA 2012, 109:17472-17477.
58. Zou J., Marjanovic J., Kisseleva M.V., Wilson M., Majerus P.W. Type I phosphatidylinositol-4,5-bisphosphate 4-phosphatase regulates stress-induced apoptosis. Proc Natl Acad Sci USA 2007, 104:16834-16839.